Literature DB >> 11986241

Erythroid differentiation and protoporphyrin IX down-regulate frataxin expression in Friend cells: characterization of frataxin expression compared to molecules involved in iron metabolism and hemoglobinization.

Erika M Becker1, Judith M Greer, Prem Ponka, Des R Richardson.   

Abstract

Friedreich ataxia (FA) is caused by decreased frataxin expression that results in mitochondrial iron (Fe) overload. However, the role of frataxin in mammalian Fe metabolism remains unclear. In this investigation we examined the function of frataxin in Fe metabolism by implementing a well-characterized model of erythroid differentiation, namely, Friend cells induced using dimethyl sulfoxide (DMSO). We have characterized the changes in frataxin expression compared to molecules that play key roles in Fe metabolism (the transferrin receptor [TfR] and the Fe transporter Nramp2) and hemoglobinization (beta-globin). DMSO induction of hemoglobinization results in a marked decrease in frataxin gene (Frda) expression and protein levels. To a lesser extent, Nramp2 messenger RNA (mRNA) levels were also decreased on erythroid differentiation, whereas TfR and beta-globin mRNA levels increased. Intracellular Fe depletion using desferrioxamine or pyridoxal isonicotinoyl hydrazone, which chelate cytoplasmic or cytoplasmic and mitochondrial Fe pools, respectively, have no effect on frataxin expression. Furthermore, cytoplasmic or mitochondrial Fe loading of induced Friend cells with ferric ammonium citrate, or the heme synthesis inhibitor, succinylacetone, respectively, also had no effect on frataxin expression. Although frataxin has been suggested by others to be a mitochondrial ferritin, the lack of effect of intracellular Fe levels on frataxin expression is not consistent with an Fe storage role. Significantly, protoporphyrin IX down-regulates frataxin protein levels, suggesting a regulatory role of frataxin in Fe or heme metabolism. Because decreased frataxin expression leads to mitochondrial Fe loading in FA, our data suggest that reduced frataxin expression during erythroid differentiation results in mitochondrial Fe sequestration for heme biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986241     DOI: 10.1182/blood.v99.10.3813

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol.

Authors:  Des R Richardson; Darius J R Lane; Erika M Becker; Michael L-H Huang; Megan Whitnall; Yohan Suryo Rahmanto; Alex D Sheftel; Prem Ponka
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-21       Impact factor: 11.205

Review 2.  Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders.

Authors:  Sweta Shah; Marc Marie Dooms; Sofia Amaral-Garcia; Mariana Igoillo-Esteve
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

Review 3.  A general map of iron metabolism and tissue-specific subnetworks.

Authors:  Valerie Hower; Pedro Mendes; Frank M Torti; Reinhard Laubenbacher; Steven Akman; Vladmir Shulaev; Suzy V Torti
Journal:  Mol Biosyst       Date:  2009-03-06

4.  Human BAC-mediated rescue of the Friedreich ataxia knockout mutation in transgenic mice.

Authors:  Joseph P Sarsero; Lingli Li; Timothy P Holloway; Lucille Voullaire; Sophie Gazeas; Kerry J Fowler; Denise M Kirby; David R Thorburn; Adam Galle; Surindar Cheema; Michel Koenig; Robert Williamson; Panos A Ioannou
Journal:  Mamm Genome       Date:  2004-05       Impact factor: 2.957

Review 5.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

6.  Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant.

Authors:  Michael Li-Hsuan Huang; Erika M Becker; Megan Whitnall; Yohan Suryo Rahmanto; Prem Ponka; Des R Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-04       Impact factor: 11.205

Review 7.  Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.

Authors:  A Anzovino; D J R Lane; M L-H Huang; D R Richardson
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 8.  Molecular Details of the Frataxin-Scaffold Interaction during Mitochondrial Fe-S Cluster Assembly.

Authors:  Courtney J Campbell; Ashley E Pall; Akshata R Naik; Lindsey N Thompson; Timothy L Stemmler
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

9.  Therapeutic approaches to delay the onset of Alzheimer's disease.

Authors:  Raj Kumar; Hani Atamna
Journal:  J Aging Res       Date:  2011-03-03

10.  Activated Oncogenic Pathway Modifies Iron Network in Breast Epithelial Cells: A Dynamic Modeling Perspective.

Authors:  Julia Chifman; Seda Arat; Zhiyong Deng; Erica Lemler; James C Pino; Leonard A Harris; Michael A Kochen; Carlos F Lopez; Steven A Akman; Frank M Torti; Suzy V Torti; Reinhard Laubenbacher
Journal:  PLoS Comput Biol       Date:  2017-02-06       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.